Surmodics Inc reports results for the quarter ended in September - Earnings Summary

SurModics

09/11/2022 14:33

* Surmodics Inc  SRDX.OQ  reported a quarterly adjusted loss
of 26
cents​​ per share for the quarter ended in September. The mean
expectation of four analysts for the quarter was for a loss
of 45 cents per share.
    * Revenue rose 8.4% to $25.99 million from a year ago;
analysts
expected $24.26 million. 
    * Surmodics Inc's reported EPS for the quarter was a loss of
$1.06​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Surmodics Inc shares had risen by 12.9% this quarter and
lost 28.7% so far this year.
    * The company reported a quarterly loss of $14.73 million.
    * Wall Street's median 12-month price target for Surmodics
Inc is
$68.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
9 at 02:32 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.45          -0.26          Beat
 Jun. 30 2022      -0.38          -0.34          Beat
 Mar. 31 2022      -0.34          -0.22          Beat
 Dec. 31 2021      -0.31          -0.13          Beat